Intratumoral Tregs from non‐small‐cell lung cancer and colorectal cancer had higher expression of several checkpoint receptors including CTLA‐4, TIGIT, and ICOS and had stronger capacity to suppress proliferation of autologous effector T cells as compared to Tregs purified from peripheral blood or normal tissue [41]. The gene discussed is ICOS; the disease is colorectal cancer.